Your browser doesn't support javascript.
loading
Wave comparisons of clinical characteristics and outcomes of COVID-19 admissions - Exploring the impact of treatment and strain dynamics.
Freeman, Anna; Watson, Alastair; O'Regan, Paul; Wysocki, Oskar; Burke, Hannah; Freitas, Andre; Livingstone, Robert; Dushianthan, Ahilanadan; Celinski, Michael; Batchelor, James; Phan, Hang; Borca, Florina; Fitzpatrick, Paul; Landers, Donal; Wilkinson, Tom Ma.
Afiliação
  • Freeman A; Faculty of Medicine, University of Southampton, United Kingdom; University Hospitals Southampton NHS Foundation Trust, United Kingdom. Electronic address: a.freeman@soton.ac.uk.
  • Watson A; Faculty of Medicine, University of Southampton, United Kingdom; University Hospitals Southampton NHS Foundation Trust, United Kingdom.
  • O'Regan P; Digital Experimental Cancer Medicine Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, The University of Manchester, United Kingdom.
  • Wysocki O; Digital Experimental Cancer Medicine Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, The University of Manchester, United Kingdom; Department of Computer Science, The University of Manchester, United Kingdom.
  • Burke H; Faculty of Medicine, University of Southampton, United Kingdom; University Hospitals Southampton NHS Foundation Trust, United Kingdom.
  • Freitas A; Digital Experimental Cancer Medicine Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, The University of Manchester, United Kingdom; Department of Computer Science, The University of Manchester, United Kingdom; Idiap Research Institute, Switzerland.
  • Livingstone R; Faculty of Medicine, University of Southampton, United Kingdom; University Hospitals Southampton NHS Foundation Trust, United Kingdom.
  • Dushianthan A; Faculty of Medicine, University of Southampton, United Kingdom; University Hospitals Southampton NHS Foundation Trust, United Kingdom; NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, United Kingdom.
  • Celinski M; Faculty of Medicine, University of Southampton, United Kingdom; University Hospitals Southampton NHS Foundation Trust, United Kingdom.
  • Batchelor J; Faculty of Medicine, University of Southampton, United Kingdom; University Hospitals Southampton NHS Foundation Trust, United Kingdom; Institute for Life Sciences, University of Southampton, United Kingdom; Clinical Informatics Research Unit Faculty of Medicine, University of Southampton,United King
  • Phan H; Faculty of Medicine, University of Southampton, United Kingdom; Clinical Informatics Research Unit Faculty of Medicine, University of Southampton,United Kingdom; NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, United Kingdom.
  • Borca F; Faculty of Medicine, University of Southampton, United Kingdom; University Hospitals Southampton NHS Foundation Trust, United Kingdom; Clinical Informatics Research Unit Faculty of Medicine, University of Southampton,United Kingdom; NIHR Southampton Biomedical Research Centre, University Hospital So
  • Fitzpatrick P; Digital Experimental Cancer Medicine Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, The University of Manchester, United Kingdom.
  • Landers D; Digital Experimental Cancer Medicine Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, The University of Manchester, United Kingdom.
  • Wilkinson TM; Faculty of Medicine, University of Southampton, United Kingdom; University Hospitals Southampton NHS Foundation Trust, United Kingdom.
J Clin Virol ; 146: 105031, 2022 01.
Article em En | MEDLINE | ID: mdl-34844145

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article